197 related articles for article (PubMed ID: 32614092)
1. Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells.
Salazar-Roa M; Trakala M; Álvarez-Fernández M; Valdés-Mora F; Zhong C; Muñoz J; Yu Y; Peters TJ; Graña-Castro O; Serrano R; Zapatero-Solana E; Abad M; Bueno MJ; Gómez de Cedrón M; Fernández-Piqueras J; Serrano M; Blasco MA; Wang DZ; Clark SJ; Izpisua-Belmonte JC; Ortega S; Malumbres M
EMBO J; 2020 Aug; 39(16):e104324. PubMed ID: 32614092
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
[TBL] [Abstract][Full Text] [Related]
3. miR-6539 is a novel mediator of somatic cell reprogramming that represses the translation of Dnmt3b.
Wu F; Tao L; Gao S; Ren L; Wang Z; Wang S; Tian J; An L
J Reprod Dev; 2017 Aug; 63(4):415-423. PubMed ID: 28603220
[TBL] [Abstract][Full Text] [Related]
4. Physoxia Influences Global and Gene-Specific Methylation in Pluripotent Stem Cells.
Dogan F; Aljumaily RMK; Kitchen M; Forsyth NR
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628663
[TBL] [Abstract][Full Text] [Related]
5. De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells.
Fukuda A; Hazelbaker DZ; Motosugi N; Hao J; Limone F; Beccard A; Mazzucato P; Messana A; Okada C; San Juan IG; Qian M; Umezawa A; Akutsu H; Barrett LE; Eggan K
Stem Cell Reports; 2021 Sep; 16(9):2138-2148. PubMed ID: 34416176
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA.
Senyuk V; Premanand K; Xu P; Qian Z; Nucifora G
PLoS One; 2011; 6(6):e20793. PubMed ID: 21695170
[TBL] [Abstract][Full Text] [Related]
7. Persistent epigenetic memory impedes rescue of the telomeric phenotype in human ICF iPSCs following DNMT3B correction.
Toubiana S; Gagliardi M; Papa M; Manco R; Tzukerman M; Matarazzo MR; Selig S
Elife; 2019 Nov; 8():. PubMed ID: 31738163
[TBL] [Abstract][Full Text] [Related]
8. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
9. MiR-455-3p inhibits the degenerate process of chondrogenic differentiation through modification of DNA methylation.
Sun H; Zhao X; Zhang C; Zhang Z; Lun J; Liao W; Zhang Z
Cell Death Dis; 2018 May; 9(5):537. PubMed ID: 29748607
[TBL] [Abstract][Full Text] [Related]
10. De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state.
Pawlak M; Jaenisch R
Genes Dev; 2011 May; 25(10):1035-40. PubMed ID: 21576263
[TBL] [Abstract][Full Text] [Related]
11. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types.
Ziller MJ; Müller F; Liao J; Zhang Y; Gu H; Bock C; Boyle P; Epstein CB; Bernstein BE; Lengauer T; Gnirke A; Meissner A
PLoS Genet; 2011 Dec; 7(12):e1002389. PubMed ID: 22174693
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Differentiation Potential of Already-Established Pluripotent Stem Cells.
González-Martínez J; Malumbres M
Methods Mol Biol; 2022; 2454():95-107. PubMed ID: 34128208
[TBL] [Abstract][Full Text] [Related]
13. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
14. Generation of human induced pluripotent stem cells using epigenetic regulators reveals a germ cell-like identity in partially reprogrammed colonies.
Goyal A; Chavez SL; Reijo Pera RA
PLoS One; 2013; 8(12):e82838. PubMed ID: 24349377
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms.
Gao L; Emperle M; Guo Y; Grimm SA; Ren W; Adam S; Uryu H; Zhang ZM; Chen D; Yin J; Dukatz M; Anteneh H; Jurkowska RZ; Lu J; Wang Y; Bashtrykov P; Wade PA; Wang GG; Jeltsch A; Song J
Nat Commun; 2020 Jul; 11(1):3355. PubMed ID: 32620778
[TBL] [Abstract][Full Text] [Related]
16. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer.
Chen BF; Gu S; Suen YK; Li L; Chan WY
Epigenetics; 2014 Jan; 9(1):119-28. PubMed ID: 23959088
[TBL] [Abstract][Full Text] [Related]
17. MiR-495 suppresses mesendoderm differentiation of mouse embryonic stem cells via the direct targeting of Dnmt3a.
Yang D; Wang G; Zhu S; Liu Q; Wei T; Leng Y; Duan T; Kang J
Stem Cell Res; 2014 Mar; 12(2):550-61. PubMed ID: 24530979
[TBL] [Abstract][Full Text] [Related]
18. microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming.
Guo X; Liu Q; Wang G; Zhu S; Gao L; Hong W; Chen Y; Wu M; Liu H; Jiang C; Kang J
Cell Res; 2013 Jan; 23(1):142-56. PubMed ID: 23266889
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
20. Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos.
Takada S; Berezikov E; Choi YL; Yamashita Y; Mano H
RNA; 2009 Aug; 15(8):1507-14. PubMed ID: 19509302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
